H2-M, be faciliator of MHC class II peptide loading, and its negative modulator H2-O are differentially expressed in response to proinflammatory cytokines

Immunogenetics

Volumn 51, Issue 10, 2000, Pages 794-804

  Walter, Wolfgang ^a   Scheuer, Claudia ^a   Lingnau, Karen ^a   Reichert, Torsten E ^a   Schmitt, Edgar ^a   Loos, Michael ^a   Maeurer, Markus J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Antigen presenting cells; Cytokine; H2 M; H2 O; MHC class II antigen presentation

Indexed keywords

CYTOKINE; DIMER; GAMMA INTERFERON; HLA DM ANTIGEN; HLA DO ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR; B LYMPHOCYTE ANTIGEN; H 2O ANTIGEN; H-2O ANTIGEN; H2 M ANTIGENS; H2-M ANTIGENS; HLA ANTIGEN CLASS 2; HLA D ANTIGEN; HLA DMB; HLA DO ANTIGENS; HLA-DMB; HLA-DO ANTIGENS; MESSENGER RNA; MHC CLASS II TRANSACTIVATOR PROTEIN; NUCLEAR PROTEIN; PEPTIDE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; LYMPHOID TISSUE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; DBA MOUSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INVARIANT CHAIN; TISSUE DISTRIBUTION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-D ANTIGENS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; MICE; MICE, INBRED DBA; NUCLEAR PROTEINS; PEPTIDES; RNA, MESSENGER; TISSUE DISTRIBUTION; TRANS-ACTIVATORS;

EID: 0033862355     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510000210     Document Type: Article

References (46)

1. Boehm U, Klamp T, Groot M, Howard JC (1997) Cellular responses to interferon-gamma. Annu Rev Immunol 15:749-795
2. Chang CH, Guerder S, Hong SC, Ewijk W van, Flavell RA (1996) Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167-178
3. Cho SG, Attaya M, Monaco JJ (1991) New class II-like genes in the murine MHC. Nature 353:573-576
4. Cresswell P (1996) Invariant chain structure and MHC class II function. Cell 84:505-507
5. Denzin LK, Cresswell P (1995) HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 82:155-165
6. Denzin LK, Sant'Angelo DB, Hammond C, Surman MJ, Cresswell P (1997) Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 278:106-109
7. Douek DC, Altmann DM (1997) HLA-DO is an intracellular class II molecule with distinctive thymic expression. Int Immunol 9:355-364
8. Fling SP, Arp B, Pious D (1994) HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368:554-558
9. Fung Leung WP, Surh CD, Liljedahl M, Pang J, Leturcq D, Peterson PA, Webb SR, Karlsson L (1996) Antigen presentation and T cell development in H2-M-deficient mice. Science 271:1278-1281
10. Geuze HJ (1998) The role of endosomes and lysosomes in MHC class II functioning. Immunol Today 19:282-287
11. Ham SM van, Tjin EPM, Lillemeier BF, Gruneberg U, Meijgaarden KE van, Pastoors L, Verwoerd D, Tulp A, Canas B, Rahman D, Ottenhoff TH, Pappin DJ, Trowsdale J, Neefjes J (1997) HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr Biol 7:950-957
12. Hammond C, Denzin LK, Pan M, Griffith JM, Geuze HJ, Cresswell P (1998) The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, DM, and -DO molecules. J Immunol 161:3282-3291
13. Kappler JW, Skidmore B, White J, Marrack, P (1981) Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas: lack of independent antigen and H-2 recognition. J Exp Med 153:1198-1214
14. Karlsson L, Surh CD, Sprent J, Peterson PA (1991) A novel class II MHC molecule with unusual tissue distribution. Nature 351:485-488
15. Karlsson L, Surh CD, Sprent J, Peterson PA (1992) An unusual class II molecule. Immunol Today 13:469-470
16. Kelly AP, Monaco JJ, Cho SG, Trowsdale J (1991) A new human HLA class II-related locus, DM. Nature 353:571-573
17. Kropshofer H, Vogt AB, Thery C, Armandola EA, Li BC, Moldenhauer G, Amigorena S, Hammerling GJ (1998) A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. EMBO J 17:2971-2981
18. Liljedahl M, Kuwana T, Fung Leung WP, Jackson MR, Peterson PA, Karlsson L (1996) HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J 15:4817-4824
19. Liljedahl M, Winqvist O, Surh CD, Wong P, Ngo K, Teyton L, Peterson PA, Brunmark A, Rudensky AY, Fung Leung WP, Karlsson L (1998) Altered antigen presentation in mice lacking H2-O. Immunity 8:233-243
20. Lindstedt R, Liljedahl M, Peleraux A, Peterson PA, Karlsson L (1995) The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif. Immunity 3:561-572
21. Mach B, Steimle V, Martinez Soria E, Reith W (1996) Regulation of MHC class II genes: lessons from a disease. Annu Rev Immunol 14:301-331
22. Maeurer M, Seliger B, Trinder P, Gerdes J, Seitzer U (1999) Interleukin-15 in mycobacterial infection of antigen presenting cells. Scand J Immunol 50:280-288
23. Martin WD, Hicks GG, Mendiratta SK, Leva HI, Ruley HE, Van Kaer L (1996) H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 84:543-550
24. Mathis DJ, Benoist C, Williams VE, Kanter M, McDevitt HO (1983) Several mechanisms can account for defective E alpha gene expression in different mouse haplotypes. Proc Natl Acad Sci USA 80:273-277
25. Metlay JP, Witmer Pack MD, Agger R, Crowley MT, Lawless D, Steinman RM (1990) The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J Exp Med 171:1753-1771
26. Miyazaki T, Wolf P, Tourne S, Waltzinger C, Dierich A, Barois N, Ploegh H, Benoist C, Mathis D (1996) Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84:531-541
27. Momburg F, Koch N, Moller P, Moldenhauer G, Butcher GW, Hammerling GJ (1986) Differential expression of Ia and Ia-associated invariant chain in mouse tissues after in vivo treatment with IFN-gamma. J Immunol 136:940-948
28. Morris P, Shaman J, Attaya M, Amaya M, Goodman S, Bergman C, Monaco JJ, Mellins E (1994) An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368:551-554
29. O'hUigin C, Figueroa F (1997) The DM and DN/DO loci. In: Blancher A, Klein J, Socha WW (eds) Molecular biology and evolution of blood group and MHC antigens in primates. Springer, Berlin Heidelberg New York, pp 423-430
30. Otten LA, Steimle V, Bontron S, Mach B (1998) Quantitative control of MHC class II expression by the transactivator CIITA. Eur J Immunol 28:473-478
31. Ozato K, Mayer N, Sachs DH (1980) Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol 124:533-540
32. Platzer C, Richter G, Uberla K, Muller W, Blocker H, Diamantstein T, Blankenstein T (1992) Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction. Eur J Immunol 22:1179-1184
33. Ponzoni M, Guarnaccia F, Corrias MV, Cornaglia Ferraris P (1993) Uncoordinate induction and differential regulation of HLA class-I and class-II expression by gamma-interferon in differentiating human neuroblastoma cells. Int J Cancer 55:817-823, 1993
34. Reichert TS, Watkins S, Stanson J, Johnson JT, Whiteside L (1998) Endogenous IL-2 in cancer cells: a marker of cellular proliferation. J Histochem Cytochem 46:603-611
35. Riberdy JM, Newcomb JR, Surman MJ, Barbosa JA, Cresswell P (1992) HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 360:474-477
36. Rock KL, Benacerraf B, Abbas AK (1984) Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J Exp Med 160:1102-1113
37. Salomon RN, Underwood R, Doyle MV, Wang A, Libby P (1992) Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma. Proc Natl Acad Sci USA 89:2814-2818
38. Stavnezer J (1996) Antibody class switching. Adv Immunol 61:79-146
39. Tonnelle C, DeMars R, Long EO (1985) DO beta: a new beta chain gene in HLA-D with a distinct regulation of expression. EMBO J 4:2839-2847
40. Trowsdale J (1995) "Both man & bird & beast": comparative organization of MHC genes. Immunogenetics 41:1-17
41. Ullrich HJ, Doring K, Gruneberg U, Jahnig F, Trowsdale J, Ham SM van (1997) Interaction between HLA-DM and HLA-DR involves regions that undergo conformational changes at lysosomal pH. Proc Natl Acad Sci USA 94:13163-13168
42. Wake CT, Flavell RA (1985) Multiple mechanisms regulate the expression of murine immune response genes. Cell 42:623-628
43. Walter W, Loos M, Maeurer MJ (1996) H2-M polymorphism in mice susceptible to collagen-induced arthritis involves the peptide binding groove. Immunogenetics 44:19-26
44. Watts C (1997) Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 15:821-850
45. Westerheide SD, Louis Plence P, Ping D, He XF, Boss JM (1997) HLA-DM A and HLA-DMB gene expression functions through the conserved S-X-Y region. J Immunol 158:4812-4821
46. Wolf PR, Ploegh HL (1995) How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu Rev Cell Dev Biol 11:267-306